Insight journal - Company

Actelion: M&A activity 2009-2014

Posted on 10 February 2014

Tags: , , ,

Actelion has announced only 1 M&A deal since 2009, with the deal being the acquisition of Ceptaris Therapeutics.Abstracted from: Partnering Agreements with Actelion 2009-2014

Actelion is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical / biotechnology companies. Actelion has strengthened its position in the oncology market with its acquisition of Ceptaris.

Actelion acquired the company Ceptaris in 2013 for a purchase price of $250 million after the approval of the T-cell lymphoma drug that Ceptaris produced.

Actelion announced the termination of its option to acquire Trophos following the communication of phase III results in patients suffering from amyotrophic lateral sclerosis (ALS).

View the full details of the deals at Current Agreements (subscription required)

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Actelion 2009-2014

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Partnering Agreements with Actelion 2009-2014

More

Summary profile data for Actelion

Partnering interests for Actelion

Partnering activity for Actelion 

 

Available reports from Current Partnering

Report: Partnering Agreements with Actelion 2009-2014

Report: Partnering Deals and Alliances with Big Biotech

 

Available resources for deal coverage for Actelion

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Actelion company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply